Navigation Links
AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
Date:1/6/2009

CARLSBAD, Calif., Jan. 6 /PRNewswire/ -- AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that the company has been invited and has accepted to present at the JPMorgan Healthcare Conference, which will be held January 12-15, 2009 at the Westin St. Francis Hotel in San Francisco, CA. At this conference, Fareed Kureshy, President & CEO will provide an overview of the Company at 11:00am on Tuesday, January 13, 2009.

About JPMorgan 27th Annual Healthcare Conference: JPMorgan's premier annual conference on the healthcare industry will feature more than 300 public and private companies over four days of simultaneous sessions.

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed an automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com


'/>"/>
SOURCE AutoGenomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
2. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
3. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
4. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
7. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
8. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
9. Thoratec Presentation at J.P. Morgan Conference to be Webcast
10. West to Present at Upcoming Conferences
11. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... ... Inc. will hold its annual technology show and open house, Southern Tech Fest, ... machinery from Okuma, Tsugami, Hardinge Group and Chiron and perform live metal cutting ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... formed a strategic partnership to develop and market automated chromatographic solutions for ... automated testing solutions will save analysis time and reduce labor costs, while ...
(Date:2/28/2017)... Australien, 28. Februar 2017  ITL Limited ... Anbieter und strategischer Partner des Bereiches Medizintechnik ... Gesundheitsbereich, das individuelle Gesundheitsversorgung f√∂rdert, gibt offiziell ... (ITL) bekannt. Die Umbenennung ... der neuen Markenidentit√§t und wird durch die ...
(Date:2/28/2017)... ... February 28, 2017 , ... Patient travel ... and expertise. Colpitts Clinical Trial Travel and Expense , a division of ... unique need within the biotechnology and pharmaceutical industries in the United States, Europe, ...
Breaking Biology Technology:
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
Breaking Biology News(10 mins):